ChenGuang Biotech Group Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
ChenGuang Biotech Group Co., Ltd. carries a market capitalization of 4.69B, placing it among publicly traded companies globally. Its enterprise value stands at 9.12B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.69B |
| Enterprise Value | 9.12B |
Share Statistics
ChenGuang Biotech Group Co., Ltd. currently has 483.10M shares outstanding.
| Shares Outstanding | 483.10M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
ChenGuang Biotech Group Co., Ltd. trades at a trailing price-to-earnings ratio of 21.87. The price-to-sales ratio is 1.15, and the price-to-book ratio stands at 2.13.
| PE Ratio | 21.87 |
| PS Ratio | 1.15 |
| PB Ratio | 2.13 |
| P/TBV Ratio | 1.83 |
| P/FCF Ratio | 59.32 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, ChenGuang Biotech Group Co., Ltd. trades at an EV/EBITDA multiple of 24.84 and an EV/FCF ratio of 55.93. The EV/Sales ratio of 1.79 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 24.84 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.79 |
| EV / EBITDA | 24.84 |
| EV / EBIT | 24.84 |
| EV / FCF | 55.93 |
Financial Position
ChenGuang Biotech Group Co., Ltd. maintains a current ratio of 1.24, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 187.68, indicating elevated leverage, while an interest coverage ratio of 4.92 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.24 |
| Quick Ratio | 0.47 |
| Debt / Equity | 187.68 |
| Debt / EBITDA | 18.01 |
| Interest Coverage | 4.92 |
Financial Efficiency
ChenGuang Biotech Group Co., Ltd. posts a return on equity of 10.21 and a return on invested capital of 3.24.
| Return on Equity (ROE) | 10.21 |
| Return on Assets (ROA) | 2.50 |
| Return on Invested Capital (ROIC) | 3.24 |
| Return on Capital Employed (ROCE) | 3.62 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.19 |
Taxes
Over the trailing twelve months, ChenGuang Biotech Group Co., Ltd. has paid 42.97M in income taxes, reflecting an effective tax rate of 13.64.
| Income Tax | 42.97M |
| Effective Tax Rate | 13.64 |
Stock Price Statistics
ChenGuang Biotech Group Co., Ltd.'s stock has declined approximately -26.43939% over the past 52 weeks. The 50-day moving average sits at 10.40, while the 200-day moving average is 12.49.
| Beta (5Y) | N/A |
| 52-Week Price Change | -26.43939% |
| 50-Day Moving Average | 10.40 |
| 200-Day Moving Average | 12.49 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, ChenGuang Biotech Group Co., Ltd. generated 5.08B in revenue and converted that into 267.25M in net income, yielding earnings per share of 0.56. EBITDA reached 367.12M, while operating income came in at 367.12M.
| Revenue | 5.08B |
| Gross Profit | 615.33M |
| Operating Income | 367.12M |
| Pretax Income | 314.98M |
| Net Income | 267.25M |
| EBITDA | 367.12M |
| EBIT | 367.12M |
| Earnings Per Share (EPS) | 0.56 |
Balance Sheet
ChenGuang Biotech Group Co., Ltd. holds 3.39B in cash and equivalents against 6.61B in total debt, resulting in a net debt position of 2.37B. Total book value stands at 2.75B, with working capital of 1.74B providing operational flexibility.
| Cash & Cash Equivalents | 3.39B |
| Total Debt | 6.61B |
| Net Debt | 2.37B |
| Equity (Book Value) | 2.75B |
| Book Value Per Share | 5.69 |
| Working Capital | 1.74B |
Cash Flow
After subtracting -98.55M in capital expenditures, free cash flow totaled -98.55M - equivalent to -0.20 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -98.55M |
| Free Cash Flow | -98.55M |
| FCF Per Share | -0.20 |
Margins
ChenGuang Biotech Group Co., Ltd. operates with a gross margin of 12.11, reflecting its pricing power and cost economics. The operating margin of 7.22 and net profit margin of 5.26 provide insight into operational efficiency.
| Gross Margin | 12.11 |
| Operating Margin | 7.22 |
| Pretax Margin | 6.20 |
| Profit Margin | 5.26 |
| EBITDA Margin | 7.22 |
Dividends & Yields
The company's payout ratio of 55.68 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.32 |
| Dividend Yield | N/A |
| Payout Ratio | 55.68 |
| Shareholder Yield | -30.21 |
| FCF Yield | 1.69 |
Stock Splits
ChenGuang Biotech Group Co., Ltd.'s most recent stock split took place on June 27, 2018 with a 5:7 split ratio.
| Last Split Date | 6/27/2018 |
| Split Ratio | 5:7 |
Scores
ChenGuang Biotech Group Co., Ltd. posts an Altman Z-Score of 1.54, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.54 |